TipRanks
IGC Pharma (IGC)
XASE:IGC
US Market
IGC
IGC Pharma
RESEARCH TOOLSreports
Want to see IGC full AI Analyst Report?

IGC Pharma (IGC) Income Statement

1,056 Followers

IGC Pharma Income Statement

Last quarter (Q1 2027), IGC Pharma's total revenue was $265.00K, a decrease of -19.21% from the same quarter last year. In Q1, IGC Pharma's net income was $-2.94M. See IGC Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Jun 23Mar 22
Total Revenue
$ 1.19M$ 1.27M$ 1.34M$ 911.00K$ 397.00K
Gross Profit
$ 352.00K$ 619.00K$ 733.00K$ -158.00K$ 194.00K
Operating Expenses
$ 10.55M$ 8.06M$ 10.53M$ 11.41M$ 15.62M
Depreciation and Amortization
$ 324.00K$ 464.00K$ 637.00K$ 657.00K$ 651.00K
EBITDA
$ -6.22M$ -6.66M$ -12.36M$ -10.85M$ -14.37M
Operating Income
$ -10.20M$ -7.45M$ -9.80M$ -11.57M$ -15.43M
Other Income/Expenses
$ 3.65M$ 325.00K$ -3.20M$ 65.00K$ 412.00K
Pretax Income
$ -6.55M$ -7.12M$ -13.00M$ -11.51M$ -15.02M
Net Income
$ -6.55M$ -7.12M$ -13.00M$ -11.51M$ -15.02M
Per Share Metrics
Basic EPS
$ -0.07$ -0.09$ -0.22$ -0.22$ -0.30
Diluted EPS
$ -0.07$ -0.09$ -0.22$ -0.22$ -0.30
Weighted Average Shares Outstanding
 95.04M 76.52M 58.84M 52.58M 49.99M
Weighted Average Shares Outstanding (Diluted)
 95.04M 76.52M 58.84M 52.58M 49.99M
Currency in USD

IGC Pharma Earnings and Revenue History